Thomas B Neff - Net Worth and Insider Trading

Thomas B Neff Net Worth

The estimated net worth of Thomas B Neff is at least $3 Million dollars as of 2024-04-25. Thomas B Neff is the CEO of FibroGen Inc and owns about 2,451,796 shares of FibroGen Inc (FGEN) stock worth over $3 Million. Details can be seen in Thomas B Neff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas B Neff has not made any transactions after 2019-08-22 and currently still holds the listed stock(s).

Transaction Summary of Thomas B Neff

To

Thomas B Neff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas B Neff owns 1 companies in total, including FibroGen Inc (FGEN) .

Click here to see the complete history of Thomas B Neff’s form 4 insider trades.

Insider Ownership Summary of Thomas B Neff

Ticker Comapny Transaction Date Type of Owner
FGEN FibroGen Inc 2019-08-22 director & Chief Executive Officer

Thomas B Neff Latest Holdings Summary

Thomas B Neff currently owns a total of 1 stock. Thomas B Neff owns 2,451,796 shares of FibroGen Inc (FGEN) as of August 22, 2019, with a value of $3 Million.

Latest Holdings of Thomas B Neff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FGEN FibroGen Inc 2019-08-22 2,451,796 1.02 2,500,832

Holding Weightings of Thomas B Neff


Thomas B Neff Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas B Neff has made a total of 8 transactions in FibroGen Inc (FGEN) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in FibroGen Inc is the sale of 39,636 shares on August 22, 2019, which brought Thomas B Neff around $2 Million.

Insider Trading History of Thomas B Neff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas B Neff Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas B Neff Ownership Network

Ownership Network List of Thomas B Neff

No Data

Ownership Network Relation of Thomas B Neff


Thomas B Neff Owned Company Details

What does FibroGen Inc do?

Who are the key executives at FibroGen Inc?

Thomas B Neff is the director & Chief Executive Officer of FibroGen Inc. Other key executives at FibroGen Inc include Chief Commercial Officer Thane Wettig , director & Chief Executive Officer Enrique A Conterno , and SVP & China Operations Christine Chung .

FibroGen Inc (FGEN) Insider Trades Summary

Over the past 18 months, Thomas B Neff made no insider transaction in FibroGen Inc (FGEN). Other recent insider transactions involving FibroGen Inc (FGEN) include a net purchase of 29,738 shares made by Thane Wettig , a net sale of 92,477 shares made by Enrique A Conterno , and a net sale of 39,779 shares made by Christine Chung .

In summary, during the past 3 months, insiders sold 0 shares of FibroGen Inc (FGEN) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 255,701 shares of FibroGen Inc (FGEN) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 205,701 shares.

FibroGen Inc (FGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

FibroGen Inc Insider Transactions

No Available Data

Thomas B Neff Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas B Neff. You might contact Thomas B Neff via mailing address: C/o Fibrogen, Inc., 409 Illinois St., San Francisco Ca 94158.

Discussions on Thomas B Neff

No discussions yet.